Sally Adams to Join Scancell as Development Director
Dr Sally Adams

News

Sally Adams to Join Scancell as Development Director

09 May, 2014

Published over 12 years ago. See the latest and most current information on News.

Richard Goodfellow, Joint CEO of Scancell, said:  “Sally has already worked closely with the Scancell team for several years.  She has played a key role in the planning and execution of our successful clinical trial of SCIB1 in patients with metastatic melanoma and we are delighted that Sally will be joining our Board at such a pivotal juncture in the Company’s history.  With her industry, scientific and drug development knowledge, Sally will continue to play an important role in the development of our ImmunoBody® and Moditope® platforms.”

Latest News

ILM 51.6 Sept 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Advances in vapour filtration lead to cleaner air and cleaner measurements
Explore more Arrow
Pollution Solutions Online
Kings of pollution control
Explore more Arrow
Petro Online
PFAS reference standard combines ten analytes to support trace-level calibration
Explore more Arrow
Chromatography Today
High-load peptide purification
Explore more Arrow